Yusuke Nakamura

Yusuke Nakamura

JFCR, University of Chicago, University of Tokyo, RIKEN, Cancer Institute, Univ. of Utah …
Verified email at jfcr.or.jp
Cited by 232439
Cancer Genomics Genetics Precision Medicine Drug Development
Maciej Banach

Maciej Banach

Vice-Rector for Faculty of Medicine, KUL; President, International Lipid Expert Panel, Poland
Verified email at umed.lodz.pl
Cited by 179243
Atherosclerosis Lipids Preventive Cardiology Drug Development Cardiovascular Disease
Aroon Hingorani

Aroon Hingorani

University College London
Verified email at ucl.ac.uk
Cited by 169096
Genomics drug development cardiovascular diseases multi-morbidity
Jaap Verweij

Jaap Verweij

Erasmus University Medical Center and Cancer Drug Development Forum
Verified email at cddf.org
Cited by 125574
Drug development Sarcomas
john C. Byrd

john C. Byrd

Distinguished University Professor, The Ohio State University
Verified email at osumc.edu
Cited by 114661
Hematology Drug Development
Alexander EGGERMONT

Alexander EGGERMONT

Princess Maxima Center & University Medical Center Utrecht, Netherlands alexander …
Verified email at prinsesmaximacentrum.nl
Cited by 112508
oncology immunotherapy drug development
Jean-Charles Soria

Jean-Charles Soria

Amgen R&D
Verified email at amgen.com
Cited by 112247
oncology drug development molecular biology precision medecine lung cancer
Matthew J. Ellis

Matthew J. Ellis

Guardant Health Palo Alto CA
Verified email at guardanthealth.com
Cited by 91149
drug development precision medicine breast cancer cancer genomics cancer proteomics
David A Collier

David A Collier

Independent Consultant
Verified email at kcl.ac.uk
Cited by 87041
psychosis neurodegeneration bioinformatics genomics drug development
Richard Mohs

Richard Mohs

Global Alzheimer's Platform Foundation
Verified email at globalalzplatform.org
Cited by 79282
neuroscience psychology drug development
1 - 10